Aberrant Salience Inventory
A meta‐analysis to investigate its psychometric properties and identify screening cutoff scores
Datos Bibliográficos
INTRODUCTION: The Aberrant Salience Inventory (ASI) is a useful tool to measure salience abnormalities among the general population. There is strong clinical and scientific evidence that salience alteration is linked to psychosis. To the present day, no meta-analysis evaluating ASI's psychometric properties and screening potential has been published. MATERIALS AND METHODS: PubMed, Google Scholar, Scopus, and Embase were searched using terms including "psychosis," "schizophrenia," and "Aberrant Salience Inventory." Observational and experimental studies employing ASI on populations of non-psychotic controls and patients with psychosis were included. ASI scores and other demographic measures (age, gender, ethnicity) were extracted as outcomes. Individual patients' data (IPD) were collected. Exploratory factor analysis (EFA) was performed on the IPD. RESULTS: Eight articles were finally included in the meta-analysis. ASI scores differ significantly between psychotic and non-psychotic populations; a novel three-factor model is proposed regarding subscales structure. Theoretical positive predictive values (PPVs) and negative predictive values (NPVs) were calculated and presented together with different cutoff points depending on preselected specific populations of interest. DISCUSSION: PPV and NPV values reached levels adequate for ASI to be considered a viable screening tool for psychosis. The factor analysis highlights the presence of a novel subscale that was named "Unveiling experiences." Implications regarding the meaning of the new factor structure are discussed, as well as ASI's potential as a screening tool
Cognitive psychology · Cutoff · Exploratory factor analysis · Meta-analysis · Observational study · Population · Psychiatry · Psychometrics · Psychosis · Salience (neuroscience) · Clinical Psychology · Internal Medicine · Medicine · Psychology · Psychosomatic Disorders and Their Treatments · Schizophrenia research and treatment · Tryptophan and brain disorders
The Role of Google Scholar in Evidence Reviews and Its Applicability to Grey Literature Searching
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Mapping the Onset of Psychosis
Ease
Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms
Risk‐of‐bias VISualization (robvis)
Psychosis as a State of Aberrant Salience
Updated guidance for trusted systematic reviews
Strengthening the reporting of observational studies in epidemiology (STROBE) statement
PRISMA 2020 explanation and elaboration
Making sense of Cronbach's alpha
The neurophenomenology of early psychosis
Delusional Themes Across Affective and Non-Affective Psychoses
| Obras citantes distintas | 1 |
|---|---|
| Citas por año | 0,5 |
| Intervalo de citas | 2024 - 2024 (1) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 1 |